Should atezolizumab and nab-paclitaxel now be used in first line therapy for metastatic, triple negative breast cancer?  

Have the results from IMpassion130 changed the standard of care?



Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Mayo Clinic Rochester
Here's a link to the site: http://www.vinayakkpras...
Sign in or Register to read more

Answer from: Medical Oncologist at Academic Institution
Comments
Medical Oncologist at Ralph Lauren Center for Cancer Care and Prevention
The forest plot favors >/=65y/o and PDL1 expressor...
Medical Oncologist at Cedars-Sinai Medical Center
The recent update of IMpassion130 by Leisha Emens ...
Sign in or Register to read more